These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24135441)

  • 21. Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients.
    Dumortier J; Guillaud O; Boillot O
    Liver Transpl; 2013 May; 19(5):529-33. PubMed ID: 23483701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure.
    Hougardy JM; Broeders N; Kianda M; Massart A; Madhoun P; Le Moine A; Hoang AD; Mikhalski D; Wissing KM; Abramowicz D
    Transplantation; 2011 Mar; 91(5):566-9. PubMed ID: 21192316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.
    Kolonko A; Chudek J; Wiecek A
    Transplant Proc; 2011 Oct; 43(8):2950-3. PubMed ID: 21996198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus.
    Ortega Suárez FJ; Sánchez Plumed J; Pérez Valentín MA; Pereira Palomo P; Muñoz Cepeda MA; Lorenzo Aguiar D;
    Nefrologia; 2011; 31(6):690-6. PubMed ID: 22130285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-2 profiles shortly after tacrolimus conversion from a twice-daily to once-daily regimen.
    Meçule A; Tinti F; Bachetoni A; Poli L; D'Alessandro M; Alessandri C; Umbro I; Nofroni I; Berloco PB; Mitterhofer AP
    Transplant Proc; 2011 May; 43(4):1017-9. PubMed ID: 21620040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
    van Hooff J; Van der Walt I; Kallmeyer J; Miller D; Dawood S; Moosa MR; Christiaans M; Karpf C; Undre N
    Ther Drug Monit; 2012 Feb; 34(1):46-52. PubMed ID: 22249344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Satisfaction and adherence with immunosuppressant treatment in renal transplant patients living with a working graft.
    Ortega F; Otero A; Crespo JF; Delgado JF; Borro JM; Cuervo J;
    J Nephrol; 2013; 26(2):297-305. PubMed ID: 22684646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient.
    Merli M; Di Menna S; Giusto M; Giannelli V; Lucidi C; Loria I; Ginanni Corradini S; Mennini G; Rossi M
    Transplant Proc; 2010 May; 42(4):1322-4. PubMed ID: 20534292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors.
    Meçule A; Poli L; Nofroni I; Bachetoni A; Tinti F; Umbro I; Barile M; Berloco PB; Mitterhofer AP
    Transplant Proc; 2010 May; 42(4):1317-9. PubMed ID: 20534290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden.
    Fellström B; Holmdahl J; Sundvall N; Cockburn E; Kilany S; Wennberg L
    Transplant Proc; 2018 Dec; 50(10):3275-3282. PubMed ID: 30577197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once daily tacrolimus conversion in lung transplantation: A prospective study on safety and medication adherence.
    Godinas L; Dobbels F; Hulst L; Verbeeck I; De Coninck I; Berrevoets P; Schaevers V; Yserbyt J; Dupont LJ; Verleden SE; Vanaudenaerde BM; Ceulemans LJ; Van Raemdonck DE; Neyrinck A; Verleden GM; Vos R
    J Heart Lung Transplant; 2021 Jun; 40(6):467-477. PubMed ID: 33840608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large single-center experience.
    Slatinska J; Rohal T; Wohlfahrtova M; Viklicky O
    Transplant Proc; 2013 May; 45(4):1491-6. PubMed ID: 23726604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of conversion from twice-daily tacrolimus to once-daily tacrolimus one month after transplantation: randomized controlled trial in adult renal transplantation.
    Oh CK; Huh KH; Lee JS; Cho HR; Kim YS
    Yonsei Med J; 2014 Sep; 55(5):1341-7. PubMed ID: 25048494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient outcomes and economics of once-daily tacrolimus in renal transplant patients: results of a modeling analysis.
    Abecassis MM; Seifeldin R; Riordan ME
    Transplant Proc; 2008 Jun; 40(5):1443-5. PubMed ID: 18589126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.
    Saint-Marcoux F; Debord J; Undre N; Rousseau A; Marquet P
    Ther Drug Monit; 2010 Apr; 32(2):129-35. PubMed ID: 20110850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus pharmacokinetics of once- versus twice-daily formulations in de novo kidney transplantation: a substudy of a randomized phase III trial.
    Wlodarczyk Z; Ostrowski M; Mourad M; Krämer BK; Abramowicz D; Oppenheimer F; Miller D; Dickinson J; Undre N
    Ther Drug Monit; 2012 Apr; 34(2):143-7. PubMed ID: 22406656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten-Year Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant: A Prospective Cohort Study.
    Parodi EL; La Porta E; Russo R; Marsano L; Bellino D; Paoletti E; Massarino F; Sofia A; Garibotto G; Esposito P; Murugavel A; Cappadona F; Fontana I; Viazzi F; Picciotto D
    Transplant Proc; 2020 Dec; 52(10):3112-3117. PubMed ID: 32680595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic properties of a once-daily formulation of tacrolimus in patients with renal transplantation.
    Imanishi Y; Matsui K; Ishida K; Ito S; Matsuura K; Deguchi T; Itoh Y
    Arzneimittelforschung; 2011; 61(3):191-6. PubMed ID: 21528645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Kidney Graft Recipients.
    Barreto P; Malheiro J; Vieira P; Pedroso S; Almeida M; Martins LS; Dias L; Henriques AC; Cabrita A
    Transplant Proc; 2016 Sep; 48(7):2276-2279. PubMed ID: 27742278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.